Promotions & Moves

Gilead CEO Steps Down

Milligan to succeed Martin

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

John C. Martin, Ph.D., chairman and chief executive officer of Gilead Sciences, Inc. will step down, effective March 10, 2016, and will assume the role of executive chairman of the company. John F. Milligan, Ph.D., currently president and chief operating officer, will be promoted to chief executive officer and will serve on the board of directors.   Dr. Martin joined the company in 1990 and was appointed chief executive officer in 1996. Dr. Milligan also joined Gilead in 1990 and was appointed...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters